When it comes to clinical phase III, pharmaceutical and biotechnology companies usually focus on the upcoming manufacturing scale-up and on regulatory requirements. At this stage, it is important to plan a secondary packaging strategy.

In this webinar, you will learn why secondary packaging should be integrated at an early stage of your project. Ingo Schraut, Product and Service Manager at Vetter will provide tactical insights on this issue including volume scale-up and the impact of primary packaging on secondary packaging. We will also give you a check list that includes the most important aspects that need to be covered at an early stage of the project.

Our expert will explain what is important in the choice of the correct contract manufacturing partner. CDMOs need to be able to provide optimized solutions for the whole manufacturing process, from clinical development to commercial filling and secondary packaging.

Sponsored by: Vetter

Time: 3PM London/10AM New York

Date: 14 November